A research consortium recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema–putting stool from a healthy donor in the colon of a recipient–is safe and can prevent recurrent Clostridium...
A research consortium of NIH recently began enrolling patients in a clinical trial examining whether fecal microbiota transplantation (FMT) by enema—putting stool from a healthy donor in the colon of a recipient is safe and can prevent recurrent Clostridium...
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, announced today that the first patient has been successfully dosed in a phase I clinical trial of anti-CD47 monoclonal...
Cotinga Pharmaceuticals Inc. (TSX Venture: COT) (“Cotinga” or the “Company”), a clinical-stage pharmaceutical company advancing a pipeline of targeted therapies for the treatment of cancer, today announced that it has dosed the first patient with COTI-2 in combination...
Eisai Inc. announced today the presentation of four abstracts at the 2019 Gastrointestinal Cancers Symposium (#GI19), taking place in San Francisco from January 17-19, 2019. The presentations feature the latest data from post-hoc analyses of the pivotal phase 3...
Email
Text